Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 11;10(3):656.
doi: 10.3390/biomedicines10030656.

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

Affiliations

Lipoprotein(a) Serum Levels Predict Pulse Wave Velocity in Subjects in Primary Prevention for Cardiovascular Disease with Large Apo(a) Isoforms: Data from the Brisighella Heart Study

Arrigo F G Cicero et al. Biomedicines. .

Abstract

In the last decades, high serum levels of lipoprotein(a) (Lp(a)) have been associated with increased cardiovascular disease (CVD) risk, in particular among individuals with smaller apolipoprotein(a) (apo(a)) isoforms than those with larger sizes. The aim of our analysis was to evaluate whether Lp(a) levels could predict early vascular aging, and whether smaller apo(a) isoforms had a predictive value for vascular aging different than larger apo(a) isoforms in a cohort of subjects free from CVD. We considered the data of a subset of Brisighella Heart Study (BHS) participants free from CVD (462 men and 516 women) who were clinically evaluated during the 2012 BHS population survey. Predictors of arterial stiffness, measured as carotid-femoral pulse wave velocity (cfPWV) were estimated by the application of a step-wise linear regression model. In our cohort, there were 511 subjects with small apo(a) size and 467 subjects with large apo(a) isoforms. Subjects with larger apo(a) isoform sizes had significantly lower serum levels of Lp(a). In the BHS subpopulation sample, cfPWV was predicted by age, systolic blood pressure (SBP), serum levels of high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and sex, higher HDL-C serum levels and female sex associated with lower values of cfPWV. In subjects with smaller apo(a) isoform sizes, predictors of cfPWV were age, SBP, sex and serum levels of HDL-C, being higher HDL-C serum levels and female sex associated to lower values of cfPWV. In subjects with larger apo(a) isoform sizes, cfPWV was predicted by age, SBP, serum levels of Lp(a) and sex, with female sex associated with lower values of cfPWV. In our subpopulation sample, Lp(a) did not predict cfPWV. However, in subjects with large apo(a) isoform sizes, Lp(a) was a significant predictor of arterial stiffness.

Keywords: Lp(a); apo(a); apolipoprotein(a); arterial stiffness; kringles; lipoprotein(a); pulse wave velocity.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Flow-chart resuming the selection criteria applied to the full BHS cohort to select the sub-cohort.

Similar articles

Cited by

References

    1. Peng J., Liu M.M., Liu H.H., Xu R.X., Zhu C.G., Guo Y.L., Wu N.Q., Dong Q., Cui C.J., Li J.J. Lipoprotein (a)-mediated vascular calcification: Population-based and in vitro studies. Metabolism. 2021;127:154960. doi: 10.1016/j.metabol.2021.154960. - DOI - PubMed
    1. Ruscica M., Sirtori C.R., Corsini A., Watts G.F., Sahebkar A. Lipoprotein(a): Knowns, unknowns and uncertainties. Pharmacol. Res. 2021;173:105812. doi: 10.1016/j.phrs.2021.105812. - DOI - PubMed
    1. van der Hoek Y.Y., Wittekoek M.E., Beisiegel U., Kastelein J.J., Koschinsky M.L. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms. Hum. Mol. Genet. 1993;2:361–366. doi: 10.1093/hmg/2.4.361. - DOI - PubMed
    1. Huang Z., Yang Y., Lu J., Liang J., He Y., Yu Y., Huang H., Li Q., Wang B., Li S., et al. Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study. Front. Cardiovasc. Med. 2021;8:747120. doi: 10.3389/fcvm.2021.747120. - DOI - PMC - PubMed
    1. Liu J., Liu L., Wang B., Chen S., Liu B., Liang J., Huang H., Li Q., Lun Z., Ying M., et al. Coronary Artery Disease: Optimal Lipoprotein(a) for Survival-Lower Is Better? A Large Cohort with 43,647 Patients. Front. Cardiovasc. Med. 2021;8:670859. doi: 10.3389/fcvm.2021.670859. - DOI - PMC - PubMed

LinkOut - more resources